PLEASE NOTE:

You will be asked for your PHSS membership number on checkout. If a member's price is selected without valid membership then an invoice for the difference will be sent prior to product delivery.

Account >        Basket >

Bio-contamination Characterisation, risk profiling, control, monitoring and deviation management – PHSS Technical Monograph No 20 Bio-Contamination

PHSS-Technical-Monograph-No-20-Bio-Contamination

This monograph is a detailed technical guide to bio-contamination control in controlled environments, with particular relevance to pharmaceutical and biopharmaceutical manufacturing. It explains how airborne and surface contamination can affect product quality, process reliability, and patient safety, especially in aseptic processing where sterile products are exposed to the environment during manufacture or preparation. The book also addresses non-sterile process areas where control of bioburden remains important, making it useful across a wide range of controlled and classified settings.

At the heart of the book is the idea that bio-contamination control must be managed as a system, not judged by environmental monitoring alone. It highlights the limitations of microbial sampling, including recovery efficiency, sample size, and the fact that monitoring results are only a snapshot of conditions at a given time. The monograph therefore promotes a more holistic approach based on Quality by Design (QbD), Quality Risk Management (QRM), process understanding, and strong technical, organisational, and procedural controls.

The book explains the regulatory and operational framework that governs cleanrooms and classified areas, including GMP and cGMP expectations, ISO cleanroom classifications, and EU Grade A, B, C, and D environments. It describes how barrier separation technologies such as isolators and RABS are used to reduce contamination risk, and why effective transfer procedures, gowning, sanitisation, and decontamination are essential at every interface. It also makes clear that human intervention remains one of the greatest contamination risks, particularly in critical zones where open product or sterile surfaces are exposed.

A major strength of the monograph is its practical, risk-based structure. It sets out the four essential elements of a systematic bio-contamination programme: risk profiling and microbiological characterisation, contamination control and mitigation, facility and environmental monitoring, and deviation management with root cause analysis and CAPA. It also discusses the progression from establishing control to formal control, showing how data, trending, and deviation response work together to maintain a stable state of microbiological control.

The book is especially relevant to professionals who need to design, run, audit, or improve contamination control systems. That includes manufacturing scientists, microbiologists, validation specialists, quality professionals, cleanroom managers, and anyone involved in aseptic processing or controlled-environment operations. By combining current regulatory thinking with developing technologies and a strong emphasis on patient safety, the monograph serves as both a reference text and a guide to best practice in modern bio-contamination management.

Prepared by a PHSS special interest group from the pharmaceutical industry, NHS, Suppliers and specialist consultants.

Reviewed by the MHRA

Applies to controlled environments in GMP and non sterile applications where Bioburden control is required.

Member Price £125 / Non-Member Price £175

Join PHSS Membership today and start saving.
Log in or sign up to unlock exclusive member pricing.

Price range: £125.00 through £175.00

Join PHSS Membership today and enjoy exclusive benefits! Log in or sign up to unlock member-only pricing
Contents
Contents
  • Section 1. Introduction and scope includes a review of the challenges and requirements for Bio-contamination control and cross contamination control with a holistic approach to monitoring and proactive investigations in
    response to increased risk from changes in biocontamination profiles.
  • Section 2. Bio-contamination characterisation and risk profiling. Methodologies and strategies that profile bio-contamination through establishing control, in operations and holistic monitoring.
  • Section 3. Bio-contamination control principles and best practice guidance considering Quality by Design, different processes, control attributes background environments and Barrier technologies.
  • Section 4. Bio-contamination monitoring including classical and Rapid Micro Methods (RMM).
  • Section 5. Bio-contamination Deviation management including considerations and guidance in completing investigations and undertaking corrective and preventative actions (CAPA).

The PHSS wish to acknowledge the dedicated and committed work of the PHSS Bio-contamination special interest group and support of their affiliations for SIG member participation.
The SIG member affiliations listed are those at the time of writing the monograph.
Special interest group leader from 2012: James Drinkwater – PHSS Chairman and F Ziel (Germany) Head of Aseptic processing Technologies and GMP Compliance.

Principle contributors and editorial team:
Andrew Hopkins: Senior Inspector MHRA.
Mike Davies: Director Aseptic Quality Assurance, Global Quality GSK UK.
Ian Symonds: Head of Aseptic Quality Assurance, Global Quality GSK UK.
Dr Tim Sandle: Microbiologist / QA Bio-Products Ltd UK.
Tim Eaton: Sterile manufacturing specialist, Quality Assurance, Astra Zeneca Macclesfield UK.
Una Hearty: Associate Director Microbiology & Aseptic Support Pfizer Ireland Pharmaceuticals Grange Castle Ireland.
Jim Filer: Global Quality Compliance Executive GE Healthcare and BSI ISO nominated technical expert.
Malcolm Holmes: Independent Pharmaceutical Consultant & Member of PHSS Management team.
Laura Buck PhD – Freelance scientific editor.
James Drinkwater – PHSS Chairman (2014) & F Ziel Head of Aseptic processing technology & GMP Compliance.
Tim Triggs: Director DOP Solutions and PHSS Management team member.

Principle contributors and reviewers:
Norman Gray: Senior Inspector MHRA.
Greg McGurk – Executive Inspector HPRA: Health Products
Regulatory Authority (formerly the IMB – Irish Medicines Board).
Di Morris: Pharmaceutical Solutions ex-MHRA Inspector.
Kay O’Hagan: PHSS Vice Chairperson 2014. Quality assurance and regulatory affairs, Leader of Welsh QP forum.
Phil Greaves: Microbiologist GMP compliance consultant Biotiq UK, PHSS Management team member.
Dr. C. P. McDonald: Head of Bacteriology National Bacteriology Laboratory NHS Blood and Transplant.
Steve Robbins: Deputy Head National Bacteriology Laboratory NHSBT London.
Adam Bird MSB: QC Microbiologist Oxford BioMedica (UK) Ltd UK.
David Martin: Microbiology Technical Expert, GSK Barnard Castle UK.
Julian Kay: Head of Steriles Micro & Biopharm GSK UK.
Aisling Lawton: Microbiology Pfizer Grange Castle Ireland.
Stewart Davenport: Pfizer Kalamazoo USA.
Dr Roland Guinet: RGMP Compliance and ex-AFSSAPS Senior GMP Inspector.
Alan Fisher: Dycem Ltd and Member of PHSS Management team member.
John Wallingford: Director Pharmagraph Ltd.
PHSS SIG leader 2010-2012: Tony Harrison: Hach Lange/ convenor ISO TC209 Working Group 02 – ISO 14698.
Other participants in PHSS SIG discussions: Dr Graham Steele Microserve/ University of Bedfordshire lecturer: Microbiologist/PHSS Management team member, Aisling Bonner: QA
Allergan Ireland, Alan Aldcroft: Consultant, Mark Oldcorne: All of Wales Quality Assurance Specialist Pharmacist, Tim Sizer NHS Regional Quality Assurance Pharmacist, Phil Hunt NHS Quality Assurance Pharmacist.
RMM – Rapid Micro Methods contributors: David Jones: Technical service Director Rapid Micro Bio-systems Inc. Tim Russell: Field Market Developer TSI Instruments Ltd. Scott Morris and Jackie Horridge PhD: Senior Field Applications Scientists Azbil BioVigilant, Inc. Gilberto Dalmaso: Global Aseptic processes development manager Particle Measuring Systems Italy.

ISBN Number
Additional Info

Related products